Website stats and analysis

APPROVED USES Otezla (apremilast) is a prescription medicine approved for the treatment of adult patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate. Otezla is a prescription medicine approved for the treatment of adult patients with active psoriatic arthritis. Otezla is a prescription medicine approved for the treatment of adult patients wit...

2.48 Rating by Usitestat

otezla.com was registered 1 decade 1 year ago. It has a alexa rank of #989,005 in the world. It is a domain having .com extension. It is estimated worth of $ 1,200.00 and have a daily income of around $ 5.00. As no active threats were reported recently, otezla.com is SAFE to browse.

Traffic Report

Daily Unique Visitors: 887
Daily Pageviews: 1,774

Estimated Valuation

Income Per Day: $ 5.00
Estimated Worth: $ 1,200.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 989,005
PageSpeed Score: 89 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

44.240.40.216

Hosted Country:

United States US

Location Latitude:

45.5234

Location Longitude:

-122.676

Search Engine Results For otezla.com

Otezla oral: Uses, Side Effects, Interactions, Pictures, Warnings ...

- https://www.webmd.com/drugs/2/drug-165956/otezla-oral/details

Find patient medical information for Otezla oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.


Otezla: Side effects, interactions, dosage, and more

- https://www.medicalnewstoday.com/articles/326049

Otezla for plaque psoriasis. Otezla is approved to treat moderate to severe plaque psoriasis in adults. This is the most common form of psoriasis. It's characterized ...


Apremilasti (Otezla®) | Tampereen yliopistollinen sairaala

- https://www.tays.fi/fi-FI/content/74447/22133

20. huhtikuu 2018 ... Tays / reumataudit Potilasohje 10.12.52 Apremilasti (Otezla®) Tulosta ohje tästä Vaikuttava aine Apremilasti Vaikutustapa ja käyttöaiheet ...


Reumalääkärit, ihotautilääkärit Otezla (apremilasti) - Fimea

- https://www.fimea.fi/documents/160140/765540/Otezla+DHPC+Final-FI+2016-11-07.pdf/d1a2c772-ecc5-4b2f-8517-0054092a9106

7. marraskuu 2016 ... Otezla (apremilasti) yksinään tai yhdistelmänä tautiprosessia hidastavien reumalääkkeiden. (DMARD-lääkkeiden) kanssa on tarkoitettu ...


Otezla - Amgen

- https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf

The proportion of patients with psoriatic arthritis who discontinued treatment due to any adverse reaction was 4.6% for patients taking OTEZLA 30 mg twice daily ...


National Psoriasis Foundation

- https://www.psoriasis.org/

The National Psoriasis Foundation is here to help you get the treatment you need while promoting research to find a cure for psoriasis and psoriatic arthritis.


OTEZLA 10 mg+20 mg+30 mg tabletti, kalvopäällysteinen 4+4+19 ...

- https://www.yliopistonverkkoapteekki.fi/OTEZLA-tabletti-kalvopaeaellysteinen

OTEZLA 10 mg+20 mg+30 mg tabletti, kalvopäällysteinen 4+4+19 fol. 392,67 €. Vain kirjautuneet asiakkaat voivat tilata tämän tuotteen. Ole hyvä ja kirjaudu ...


psoriasisSPEAKS: Learn About Psoriasis & How to Manage It

- https://www.psoriasis.com/

Discover psoriasisSPEAKS, a website dedicated to teaching you about psoriasis, how psoriasis is diagnosed, and providing you tips for living with psoriasis.


Otezla Prices, Coupons & Savings Tips - GoodRx

- https://www.goodrx.com/otezla

Compare prices, print coupons and get savings tips for Otezla (Apremilast) and other Psoriasis drugs at CVS, Walgreens, and other pharmacies. Prices start at ...


Otezla® (apremilast) Official Site | Psoriasis Medication

- https://www.otezla.com/

Approved Uses. Otezla® (apremilast) is a prescription medicine approved for the treatment of adult patients with moderate to severe plaque psoriasis for whom ...


Psoriaasi ja nivelpsoriaasi - Käypä hoito

- https://www.kaypahoito.fi/hoi50062

15. kesäkuu 2020 ... PASI (psoriasis area and severity index) = ihopsoriaasin ... PsARC (Psoriatic Arthritis Response Criteria) = nivelpsoriaasin aktivisuuden mittari.


Psoriasis – Wikipedia

- https://fi.wikipedia.org/wiki/Psoriasis

Psoriasis tai psoriaasi, arkikielessä lyhyesti psori, vanhalta nimeltään hilsetystauti on krooninen iholla ja nivelissä esiintyvä tulehdustauti. Psoriasis on  ...


Apremilast | Side-effects, uses, time to work - Versus Arthritis

- https://www.versusarthritis.org/about-arthritis/treatments/drugs/apremilast/

Apremilast is used to treat psoriasis and psoriatic arthritis. Find out how long it takes to work, how it's taken and possible side-effects.


Official Home Page of OTEZLA® (apremilast) for Plaque Psoriasis ...

- https://www.otezla.net/

OTEZLA® (apremilast), a treatment for moderate to severe plaque psoriasis or active psoriatic arthritis. Please see full Important Safety Information. Review the  ...


Psoriasis | Etusivu - Ask Alia

- https://www.ask-alia.com/fi/psoriasis

Näille sivuille on koottu tietoa psoriasiksesta, aina tautitietoisuudesta oireisiin, hoitoon ja arjen tukeen. Tervetuloa lukemaan lisää!


Otezla (Apremilast), an Oral PDE-4 Inhibitor, Receives FDA ...

- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665061/

Psoriatic arthritis and psoriasis, often referred to as psoriatic diseases, are autoimmune diseases characterized by chronic inflammation, tissue and organ ...


Otezla (apremilast) - CenterWatch

- https://www.centerwatch.com/directories/1067-fda-approved-drugs/listing/3974-otezla-apremilast

Otezla is specifically indicated for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy .


Otezla (apremilast) | MyTeleHealth

- https://mytelehealth.info/medicine/otezla-apremilast

What is Otezla? Otezla (apremilast) is a brand-name prescription medication. It comes as a tablet you take by mouth. Otezla is used to treat plaque psoriasis and  ...


TV Host and Fashion Journalist Louise Roe Shares Her Personal ...

- https://ir.celgene.com/press-releases-archive/press-release-details/2018/TV-Host-and-Fashion-Journalist-Louise-Roe-Shares-Her-Personal-Story-With-Plaque-Psoriasis-as-Part-of-INSIDE-PERSPECTIVE-Campaign/default.aspx

24 Oct 2018 ... Otezla is a prescription medicine approved for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or ...


Otezla - Terveyskirjasto

- https://www.terveyskirjasto.fi/far03260

Otezla. Lääkeopas Terveyskirjasto. 2.1.2019. Lääketietokeskus. Markkinoija; Vaikuttava aine; Käyttötarkoitus; Annostus; Lääkkeen ottaminen; Vaikutustapa ...

Page Resources Breakdown

Homepage Links Analysis

Otezla® (apremilast) Official Site | Psoriasis Medication
Learn about Otezla - a pill that helps treat moderate to severe plaque psoriasis differently. Visit Official Site to See Safety Info.

Website Inpage Analysis

H1 Headings: 1 H2 Headings: 18
H3 Headings: 2 H4 Headings: Not Applicable
H5 Headings: Not Applicable H6 Headings: 1
Total IFRAMEs: Not Applicable Total Images: 13
Google Adsense: Not Applicable Google Analytics: Not Applicable

Two Phrase Analysis

Words Occurrences Density Possible Spam
approved for 3 1.987 % No
medicine approved 3 1.987 % No
prescription medicine 3 1.987 % No
a prescription 3 1.987 % No
for the 3 1.987 % No
the treatment 3 1.987 % No
patients with 3 1.987 % No
adult patients 3 1.987 % No
treatment of 3 1.987 % No
is a 3 1.987 % No
of adult 3 1.987 % No
Approved Uses 2 1.325 % No
Otezla is 2 1.325 % No
copay Call 1 0.662 % No
BehÇet's Disease 1 0.662 % No
18444otezla copay 1 0.662 % No
Call Us 1 0.662 % No
Disease 18444otezla 1 0.662 % No
Us copay 1 0.662 % No
PLAQUE PSORIASIS 1 0.662 % No

Four Phrase Analysis

Words Occurrences Density Possible Spam
medicine approved for the 3 1.987 % No
prescription medicine approved for 3 1.987 % No
a prescription medicine approved 3 1.987 % No
approved for the treatment 3 1.987 % No
for the treatment of 3 1.987 % No
treatment of adult patients 3 1.987 % No
the treatment of adult 3 1.987 % No
is a prescription medicine 3 1.987 % No
of adult patients with 3 1.987 % No
Otezla is a prescription 2 1.325 % No
BehÇet's Disease 18444otezla copay 1 0.662 % No
Disease 18444otezla copay Call 1 0.662 % No
in BehÇet's Disease 18444otezla 1 0.662 % No
18444otezla copay Call Us 1 0.662 % No
ulcers in BehÇet's Disease 1 0.662 % No
Oral ulcers in BehÇet's 1 0.662 % No
copay Call Us copay 1 0.662 % No
offer HOME PLAQUE PSORIASIS 1 0.662 % No
HOME PLAQUE PSORIASIS PSORIATIC 1 0.662 % No
copay offer HOME PLAQUE 1 0.662 % No

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Sun, 04 Apr 2021 15:42:20 GMT
Content-Type: text/html; charset=utf-8
Content-Length: 174793
Connection: keep-alive
Cache-Control: no-cache, no-store
Pragma: no-cache
Expires: -1
Access-Control-Allow-Origin: *
Strict-Transport-Security: max-age=31536000
Content-Security-Policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://dusandbox.skipta.com https://doctorunite.com https://generationNP.com https://cardiologistconnect.com https://paunite.com https://cardiologistconnectsandbox.skipta.com https://next.brella.io/
X-Frame-Options: ALLOW-FROM http://www.medscape.com
X-Xss-Protection: 1; mode=block

Domain Information

Domain Registrar: MarkMonitor Inc.
Registration Date: 2013-03-23 1 decade 1 year 6 months ago
Last Modified: 2020-03-12 4 years 6 months 3 weeks ago

Domain Nameserver Information

Host IP Address Country
ns-1152.awsdns-16.org 205.251.196.128 United States United States
ns-1659.awsdns-15.co.uk 205.251.198.123 United States United States
ns-27.awsdns-03.com 205.251.192.27 United States United States
ns-527.awsdns-01.net 205.251.194.15 United States United States

DNS Record Analysis

Host Type TTL Extra
otezla.com A 293 IP: 44.240.40.216
otezla.com A 293 IP: 52.35.250.80
otezla.com NS 86400 Target: ns-27.awsdns-03.com
otezla.com NS 86400 Target: ns-527.awsdns-01.net
otezla.com NS 86400 Target: ns-1152.awsdns-16.org
otezla.com NS 86400 Target: ns-1659.awsdns-15.co.uk
otezla.com SOA 900 MNAME: ns-27.awsdns-03.com
RNAME: awsdns-hostmaster.amazon.com
Serial: 1
Refresh: 7200
Retry: 900
Expire: 1209600
otezla.com MX 14400 Priority: 20
Target: mxb-0018ee02.gslb.pphosted.com
otezla.com MX 14400 Priority: 10
Target: mxa-0018ee01.gslb.pphosted.com
otezla.com TXT 300 TXT:
facebook-domain-verification=g53lvpeazoo
lvtlax88bdiqm1le8em
otezla.com TXT 300 TXT:
google-site-verification=DJtKGtzVanrNIs0
xnIXGwAuxaMG9SfUIw_WmQuCclaw

Full WHOIS Lookup

Domain Name: OTEZLA.COM
Registry Domain ID:
1788253817_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.markmonitor.com
Registrar URL:
http://www.markmonitor.com
Updated Date:
2020-03-11T19:47:32Z
Creation Date:
2013-03-22T23:15:16Z
Registry Expiry Date:
2022-03-22T23:15:16Z
Registrar: MarkMonitor Inc.
Registrar
IANA ID: 292
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.2083895740
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS-1152.AWSDNS-16.ORG
Name Server:
NS-1659.AWSDNS-15.CO.UK
Name Server: NS-27.AWSDNS-03.COM
Name
Server: NS-527.AWSDNS-01.NET
DNSSEC: unsigned
URL of the ICANN
Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>>
Last update of whois database: 2021-04-04T15:42:18Z

Similarly Ranked Websites

Hindi Slogans - हिन्दी स्लोगन

- hindislogans.com

Hindi Slogans is India’s 1st Platform with an intent to spread awareness in the society through slogans. Having published slogans on social issues like Save Environment, Save...

989,007   $ 1,200.00

Request Rejected

- tecomgroup.ae

989,017   $ 1,200.00


Home - ISTS

- applyists.com

Industry experts in educational assistance program management for organizations with scholarship, tuition assistance/reimbursement, or grant programs.

989,030   $ 1,200.00

Shipshewana, IN | Flea Market | Auctions | Shipshewana Auction &...

- shipshewanatradingplace.com

Shipshewana Trading Place is home to the Midwest's largest flea Market, weekly auctions, and special events - A do-not-miss attraction in Northern Indiana's Amish Country.

989,031   $ 1,200.00